This is a Validated Antibody Database (VAD) review about human melanotransferrin, based on 2 published articles (read how Labome selects the articles), using melanotransferrin antibody in all methods. It is aimed to help Labome visitors find the most suited melanotransferrin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
melanotransferrin synonym: CD228; MAP97; MFI2; MTF1; MTf; melanotransferrin; antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5; melanoma-associated antigen p97; membrane-bound transferrin-like protein

Invitrogen
mouse monoclonal (MA454)
  • flow cytometry; human; fig 2a
In order to identify NFATc2 as a regulator of human melanoma dedifferentiation, Invitrogen melanotransferrin antibody (Life Technologies, MA5-11338) was used in flow cytometry on human samples (fig 2a). Oncogene (2016) ncbi
mouse monoclonal (MA454)
  • immunohistochemistry - paraffin section; human; fig 3
In order to identify and evaluate cancer-germline genes for therapeutic vaccine targets in various pediatric solid tumors, Invitrogen melanotransferrin antibody (Zymed, MA454) was used in immunohistochemistry - paraffin section on human samples (fig 3). Int J Cancer (2007) ncbi
Articles Reviewed
  1. Perotti V, Baldassari P, Molla A, Vegetti C, Bersani I, Maurichi A, et al. NFATc2 is an intrinsic regulator of melanoma dedifferentiation. Oncogene. 2016;35:2862-72 pubmed publisher
  2. Jacobs J, Brasseur F, Hulsbergen van de Kaa C, van de Rakt M, Figdor C, Adema G, et al. Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR. Int J Cancer. 2007;120:67-74 pubmed